This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04059/identifier/pdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04059/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04059/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04059/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/resource/drugbank/drug/DB04059/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04059/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04059
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB04059 n13:DB04059
dcterms:title
8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide
adms:identifier
n6:395358 n7:DB04059 n8:46506499 n9:46311 n14:UI2 n15:448610
n3:IUPAC-Name
n4:271B5D2D-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5D33-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5D32-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5D2F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5D30-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5D31-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5D2B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5D2C-363D-11E5-9242-09173F13E4C5 n4:271B5D29-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5D2A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5D39-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5D3A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5D34-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5D35-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5D37-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5D36-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5D38-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5D3F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5D41-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5D42-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5D3E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5D3D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5D40-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5D2E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5D3B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5D3C-363D-11E5-9242-09173F13E4C5